Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NRG Oncology
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NYU Langone Health
Maastricht University Medical Center
Massachusetts General Hospital
University of Texas Southwestern Medical Center
Brown University
Institut Cancerologie de l'Ouest
Institut Cancerologie de l'Ouest
University of Kansas Medical Center
Ohio State University Comprehensive Cancer Center
University of Kentucky
University of Kentucky